Bio

Lisa Deschamps joined AviadoBio a London based bio tech company, in October 2021 as Chief Executive Officer and Executive Board Member. Prior to joining, Lisa served as Senior Vice President & Chief Business Officer of Novartis Gene Therapies, a unit of Novartis where she was responsible for strategic planning and worldwide commercialization of the pipeline and in-line assets across the extensive gene therapy portfolio; including the world-wide commercialization of Zolgensma. Her career at Novartis spanned for more than twenty-five years, during which she brought products from the clinic to commercialization across many therapeutic areas, including highly Specialized, Rare and Ultra-Rare disease areas and has led teams across U.S, Europe, LatCan and Asia/Pac in Strategic, Functional and General Management roles. Lisa also served on several executive teams across commercial and development within Novartis. Lisa has an MBA in General Management from NYU Stern School of Business and a BBA in marketing from IONA College, Hagan School of Business and currently serves as a Non-Executive Director for VERONA Pharma and sits on the Strategic Advisory and serves as a Non-Executive Director for Reset Pharma. She has garnered many industry awards and honors and lends her personal time to a number of Philanthropic interests.